Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 7301 - 7325 of 8003 in total
Firocoxib is a cycooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug. It currently approved for veterinary use in dogs and horses under the brand names Equioxx and Previcox. Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses. Firocoxib is not intended or approved for use...
Experimental
Vet approved
Experimental
T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer.
Investigational
Experimental
BMS-955176 is under investigation in clinical trial NCT02415595 (Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults).
Investigational
Matched Iupac: … 3H,3aH,4H,5H,5aH,5bH,6H,7H,7aH,8H,11H,11aH,11bH,12H,13H,13aH,13bH-cyclopenta[a]chrysen-9-yl]benzoic acid
Investigational
Matched Iupac: … }-2-phenylethyl]carbamoyl}methyl)-7,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetic acid
Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety.
Investigational
Tasisulam has been used in trials studying the treatment and basic science of Melanoma, Lymphoma, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others.
Investigational
Hydroxytriptolide has been investigated for the treatment of Rheumatoid Arthritis.
Investigational
Salvinorin A has been investigated for the basic science of Pharmaceutical Preparations.
Investigational
Experimental
Experimental
Experimental
Cilnidipine is a dihydropyridine calcium antagonist. It was jointly developed by Fuji Viscera Pharmaceutical Company, Japan and Ajinomoto, Japan and approved in 1995. Compared with other calcium antagonists, cilnidipine can act on the N-type calcium channel that existing sympathetic nerve end besides acting on L-type calcium channel that similar to...
Investigational
Niludipine is a calcium channel blocker.
Experimental
Investigational
Displaying drugs 7301 - 7325 of 8003 in total